Welcome to our dedicated page for Inmode Ltd. SEC filings (Ticker: INMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for InMode Ltd. (INMD) brings together the company’s official disclosures as a foreign private issuer listed on Nasdaq. InMode files annual reports on Form 20-F and current reports on Form 6-K, which incorporate press releases on quarterly and annual financial results, guidance updates, and other material information about its RF-based medical technology business.
Through these filings, investors can review detailed financial statements that cover revenues, gross profit, operating expenses, operating income, net income, cash flows, and balance sheet data, along with management’s use of non-GAAP measures such as non-GAAP gross margin, non-GAAP operating income, and non-GAAP earnings per diluted share. The filings often attach earnings press releases as exhibits, providing context for the numbers and management commentary on macroeconomic conditions, tariffs, and regional performance.
InMode’s Form 6-K submissions also disclose legal proceedings, including a putative shareholder class action in the United States District Court for the Central District of California, captioned Cement Masons and Plasterers Local No. 502 Pension Fund v. InMode Ltd. et al. These filings summarize the allegations under Sections 10(b) and 20(a) of the Exchange Act, the procedural status of motions to dismiss, and the company’s position that it intends to deny the allegations and defend the case. They further note that InMode is unable to estimate a range of potential loss, if any, and has not recorded a related liability as of the filing dates.
On Stock Titan, InMode’s SEC filings are updated in near real time as they appear on EDGAR. AI-powered summaries help explain the key points of lengthy documents, highlighting items such as revenue trends, margin commentary, guidance changes, and material legal disclosures. Users can quickly scan Form 6-K updates tied to quarterly results, and access the broader 20-F annual report for a more comprehensive view of risk factors, business description, and governance information. This structure allows investors to navigate InMode’s regulatory record more efficiently and focus on the sections most relevant to their analysis.
InMode Ltd. filed a Form 6-K to report that the independent transaction committee of its Board of Directors has completed its review of proposals related to a potential transaction. After evaluating the final proposals with external financial and legal advisors, the committee concluded that none was adequate or in the best interests of the company and its shareholders, and has discontinued the process. InMode states it will continue to review its business, growth, and cash allocation strategies with a focus on enhancing long-term shareholder value and does not intend to provide further updates on this matter unless it deems additional disclosure appropriate or required.
InMode Ltd. filed its Annual Report on Form 20-F, outlining its medical aesthetics business and key risks for the year ended December 31, 2025. The company had 63,358,750 Ordinary Shares outstanding and held 24,975,003 Ordinary Shares as treasury shares repurchased by the company.
InMode designs, manufactures and sells minimally invasive and non-invasive energy-based devices across multiple platforms, including BodyTite, Optimas, Morpheus8, EmpowerRF, Define, Envision, IgniteRF, OptimasMAX and, in 2025, new systems Luxora and ApexRF. International (non-U.S.) sales represented about 46% of total revenue, reflecting significant global exposure.
The report emphasizes extensive risk factors: dependence on physician adoption, intense technological and pricing competition, reliance on a small number of Israeli subcontractors and suppliers, and vulnerability to regional geopolitical events, including the Israel–Hamas war and broader Middle East conflicts. It also highlights product liability exposure, cybersecurity and data privacy compliance, global trade and sanctions risk, and stringent FDA and international medical device regulations that govern product clearance, manufacturing quality and promotional practices.
InMode Ltd. reported mixed fourth quarter and full year 2025 results. Q4 2025 revenue was $103.9 million, up 6% from Q4 2024, with GAAP diluted EPS of $0.42 and non-GAAP diluted EPS of $0.46, slightly above last year’s non-GAAP level.
For full year 2025, revenue was $370.5 million, down 6% from 2024, while GAAP net income declined to $93.8 million from $181.3 million, reflecting lower operating margins and the absence of a one-time $55.1 million tax benefit recorded in 2024. Non-GAAP diluted EPS fell to $1.60 from $1.76.
GAAP gross margin eased to 79% in 2025 from 80%, and non-GAAP operating margin slipped to 26% from 33%, mainly due to higher sales and marketing expenses. The company ended 2025 with $555.3 million in cash, marketable securities and short-term deposits and returned $127.4 million through share repurchases, while noting record European revenue and that operations have not been materially affected to date by the situation in Israel.
InMode Ltd. filed a report highlighting that it is evaluating potential strategic alternatives following recent market speculation and transaction rumors. This includes consideration of a publicly announced, non-binding proposal by Steel Partners Holdings L.P. to acquire 51% of InMode’s outstanding shares.
The board previously formed a committee of independent directors to oversee the review. The committee has hired independent legal and financial advisors and will assess any matters presented to it, including proposals involving third parties or company management and their affiliates. InMode cautions there is no assurance the review will lead to any transaction or other outcome and does not plan to provide further updates unless required by law or regulation.
InMode Ltd. furnished a Form 6-K announcing it issued a press release with third quarter 2025 financial results (attached as Exhibit 99.1) and provided an update on ongoing litigation.
The company reported that a securities class action remains pending in the U.S. District Court for the Central District of California. On September 12, 2025, the Court dismissed 19 of the 24 statements identified by plaintiffs and granted leave to replead. Plaintiffs filed a second amended complaint on October 14, 2025, and the company intends to file a motion to dismiss. InMode states it cannot estimate a range of loss, if any, from this matter and has not recorded a liability. The defendants continue to deny the allegations and plan to vigorously defend the case.
InMode Ltd. provides an update on a previously disclosed U.S. shareholder class action lawsuit filed in February 2024 in the Central District of California. The case, brought by Cement Masons and Plasterers Local No. 502 Pension Fund, alleges violations of U.S. securities laws based on purportedly false or misleading statements about the company’s business, operations, sales practices and financial outlook, and seeks unspecified damages.
InMode filed a motion to dismiss the amended complaint in April 2025, and briefing on that motion concluded in July 2025. On September 12, 2025, the Court dismissed with leave to amend 19 of the 24 challenged statements in the amended complaint. InMode states it cannot estimate any potential loss from this case and has not recorded a related liability, and the defendants intend to continue to deny the allegations and vigorously defend against the claims.